2-(1-吡咯烷基)苯甲醛 | 58028-74-3

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 中文名称: 2-(1-吡咯烷基)苯甲醛
• 中文别名: 2-(1H-吡咯)苯甲醛；2-吡咯烷-1-苯甲醛
• 英文名称: 2-pyrrolidin-1-ylbenzaldehyde
• 英文别名: 2-(1-pyrrolidinyl)benzaldehyde；2-pyrrolidinylbenzaldehyde；o-pyrrolidinobenzaldehyde；o-pyrrolidinyl benzaldehyde
• CAS: 58028-74-3
• 化学式: C₁₁H₁₃NO
• mdl: MFCD03419322
• 分子量: 175.23
• InChiKey: QJHUKBIDTDKVSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933990090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  室温和干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Pyrrolidinobenzaldehyde
Synonyms: 2-Pyrrolidin-1-ylbenzaldehyde

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Pyrrolidinobenzaldehyde
CAS number: 58028-74-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H13NO
Molecular weight: 175.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(1-吡咯烷基)苯甲醛 在 盐酸羟胺 作用下， 以 乙醇 为溶剂， 反应 18.0h， 以88%的产率得到6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium chloride
  参考文献：
  名称：

  稠合吲唑环体系的合成及其在氢溴酸尼杰拉宁中的应用

  摘要：

  描述了稠合三环哒嗪并[1,2- a ]吲唑环体系的一步合成。晶体学揭示的结构细节解释了意想不到的反应性。该方法应用于氢溴酸尼加拉宁的克级合成。

  DOI：

  10.1021/ol300303s
• 作为产物：
  描述：

  在 重水 作用下， 以 氘代乙腈 、 乙腈 为溶剂， 反应 48.0h， 生成 2-(1-吡咯烷基)苯甲醛
  参考文献：
  名称：

  光开关亚胺：芳基亚氨基吡唑在可见光下定量转化为长寿命的 Z 异构体

  摘要：

  芳基亚胺由于其可回收性和易于合成而在动态共价材料中提供了前景。然而，它们的光触发E / Z异构现象却很少受到关注。这是由于其亚稳态（<60 id=25>Z 异构体）的低热稳定性、表现出出色的抗疲劳性以及在室温下的热半衰期长达 19.2 小时等挑战造成的。此外，它们还表现出 T可见光照射下的光致变色特性、定量组装和可接近性使这些光开关有别于其基于偶氮的类似物，这些发现为下一代光响应动态共价材料开辟了道路。通过这些新的光致变色联系和光控动态组合化学的进一步探索。

  DOI：

  10.1039/d3sc05841g

文献信息

• Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders
  作者：Justin S. Cisar、Olivia D. Weber、Jason R. Clapper、Jacqueline L. Blankman、Cassandra L. Henry、Gabriel M. Simon、Jessica P. Alexander、Todd K. Jones、R. Alan B. Ezekowitz、Gary P. O’Neill、Cheryl A. Grice

  DOI：10.1021/acs.jmedchem.8b00951

  日期：2018.10.25

  of hexafluoroisopropyl carbamate-based irreversible inhibitors of MGLL, culminating in a highly potent, selective, and orally available, CNS-penetrant MGLL inhibitor, 28 (ABX-1431). Activity-based protein profiling experiments verify the exquisite selectivity of 28 for MGLL versus other members of the serine hydrolase class. In vivo, 28 inhibits MGLL activity in rodent brain (ED50 = 0.5-1.4 mg/kg)

  丝氨酸水解酶单酰基甘油脂酶（MGLL）将内源性大麻素受体激动剂2-花生四烯酰基甘油（2-AG）和其他单酰基甘油转化为脂肪酸和甘油。MGLL的遗传或药理失活导致中枢神经系统2-AG升高，花生四烯酸和类二十烷酸相应减少，从而产生抗伤害性，抗焦虑和抗神经炎作用，而没有引起直接大麻素受体激动剂的全部精神活性作用。在这里，我们报告了基于六氟异丙基氨基甲酸酯的MGLL不可逆抑制剂的优化，最终形成了一种高效，选择性和口服的CNS渗透性MGLL抑制剂28（ABX-1431）。基于活性的蛋白质谱分析实验证明了MGLL与丝氨酸水解酶类别的其他成员相比具有28的出色选择性。在体内，28在鼠福尔马林疼痛模型中抑制了啮齿动物大脑中的MGLL活性（ED50 = 0.5-1.4 mg / kg），增加了大脑2-AG的浓度，并抑制了疼痛行为。ABX-1431（28）目前正在人类临床试验中进行评估。
• [EN] IMIDAZOTRIAZINONE COMPOUNDS<br/>[FR] COMPOSÉS D'IMIDAZOTRIAZINONE
  申请人：ENVIVO PHARMACEUTICALS INC

  公开号：WO2013142269A1

  公开（公告）日：2013-09-26

  The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9 and pharmaceutically acceptable salt thereof. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.

  本发明提供了咪唑三唑酮化合物，它们是磷酸二酯酶9的抑制剂及其药用盐。本发明还提供了用于治疗哺乳动物，包括人类，PDE9相关疾病或疾病的过程、药物组成、药物制剂和化合物的药用。
• Divergent α-functionalization of cyclic amines <i>via</i> ring construction by molecular O₂ oxidized dearomatization and ring deconstruction by aromatization-driven C–C σ-bond cleavage
  作者：Fangzhi Hu、Liang Wang、Chunyan Ge、Xinyao Li、Zhanshuai Ding、Lubin Xu、Shuai-Shuai Li

  DOI：10.1039/d1gc00941a

  日期：——

  approach to achieve the divergent α-C(sp3)–H functionalization of cyclic amines through a rationally designed ring construction and ring deconstruction strategy was developed. A variety of spiro cyclohexadienone decorated cyclic amines were obtained via ring construction by molecular O2 oxidized dearomatization/cyclization. In addition, the sequential α-C(sp3)–H bond functionalization of cyclic amines was

  开发了一种通过合理设计的环构造和环解构策略实现环胺的发散 α-C(SP 3 )-H 官能化的有效方法。通过分子O 2氧化脱芳构化/环化，通过环构建获得了多种螺环己二烯酮修饰的环胺。此外，顺序α-C（SP 3）-H键的环状胺的官能化达到经由环解构通过芳构驱动的C-C键断裂/分子间官能化通过添加不同的格氏试剂或NaBD的4。
• <i>N</i>-Alkylation-Initiated Redox-Neutral [5 + 2] Annulation of 3-Alkylindoles with <i>o</i>-Aminobenzaldehydes: Access to Indole-1,2-Fused 1,4-Benzodiazepines
  作者：Shuai Wang、Yao-Bin Shen、Long-Fei Li、Bin Qiu、Liping Yu、Qing Liu、Jian Xiao

  DOI：10.1021/acs.orglett.9b03011

  日期：2019.11.15

  [5 + 2] annulation of 3-alkylindoles with o-aminobenzaldehydes via a cascade N-alkylation/dehydration/[1,5]-hydride transfer/Friedel–Crafts alkylation sequence. A series of indole-1,2-fused 1,4-benzodiazepines are facilely constructed in moderate to good yields in one step. This protocol features excellent regioselectivity, metal-free conditions, high step economy, and wide substrate scope.

  本文描述的是通过级联N-烷基化/脱水/ [1,5]-氢化物转移/ Friedel-Crafts烷基化序列，前所未有的N-烷基化引发的3-烷基吲哚与邻氨基苯甲醛的氧化还原中性[5 + 2]环化反应。一步一步即可轻松构建一系列吲哚1,2-稠合的1,4-苯并二氮杂ze。该协议具有出色的区域选择性，无金属条件，高步骤经济性和广泛的底物范围。
• Catalyst-free photodecarbonylation of <i>ortho</i>-amino benzaldehyde
  作者：Jingwei Zhou、Lamei Li、Songping Wang、Ming Yan、Wentao Wei

  DOI：10.1039/d0gc01256d

  日期：——

  strategy, we broke this consensus and discovered a catalyst-free photodecarbonylation of the aldehyde group. It revealed that decarbonylation can be easily achieved with visible light irradiation by introducing a tertiary amine into the ortho-position of the aldehyde group. A diverse array of tertiary amines is tolerated by our photodecarbonylation under mild conditions. Furthermore, the (QM) computations

  几乎共识是，醛基（–CHO）的脱羰不仅需要通过过渡金属催化剂来介导，而且还需要严格的反应条件（高温和长反应时间）。在这项工作中，受“基于构象选择性的”设计策略的启发，我们打破了这一共识，并发现了醛基的无催化剂光脱羰基。它表明，脱羰基化可以用可见光照射能够容易地实现通过引入叔胺到邻醛基的-位置。在温和条件下，我们的光脱羰基化可以耐受各种各样的叔胺。此外，在精心设计的特殊底物上进行机理和实验的（QM）计算表明，我们的光脱羰基取决于醛基和叔胺的构象特异性，并通过异常的[1,4] -H位移和随后的[1,3] -H移位。